Position in MAZE
as of Mar 31, 2026
· filed Apr 21, 2026
Position Value
$406,228
New position
Shares Held
13,609
first reported quarter
Ownership
0.025%
of shares outstanding
% of Portfolio
1.68%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Ground Swell Capital, LLC holds $1,899,811 across 10 Biotechnology names. MAZE ranks #2 (21.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
7,285 | $547,030 | |
| 2 | MAZE |
Maze Therapeutics, Inc.
This page
|
13,609 | $406,228 | |
| 3 | AGIO |
Agios Pharmaceuticals, Inc.
|
8,347 | $282,379 | |
| 4 | ANAB |
Anaptysbio, Inc
|
7,610 | $281,366 | |
| 5 | BNTX |
BioNTech SE
|
2,904 | $258,107 | |
| 6 | ABCL |
AbCellera Biologics Inc.
|
15,820 | $55,211 | |
| 7 | RCKT |
Rocket Pharmaceuticals, Inc.
|
14,001 | $50,123 | |
| 8 | PMCB |
PharmaCyte Biotech, Inc.
|
11,527 | $7,670 |
All Filings in MAZE
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $406,228 | 13,609 | Shares | Sole | 2026-04-21 | |
| No filing history on record for this holder in this stock. | ||||||